At the time of conducting this study, Christopher M. Jones was with the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA. Emily O. Olsen, Julie O'Donnell, and Desiree Mustaquim were with the Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention.
Am J Public Health. 2020 Apr;110(4):509-516. doi: 10.2105/AJPH.2019.305527. Epub 2020 Feb 20.
To evaluate trends and correlates of methamphetamine use in the United States. Data are from 15 747 334 drug-related treatment admissions among persons aged 12 years or older in the 2008-2017 Treatment Episode Data Set. We analyzed trends and used multivariable logistic regression. Methamphetamine-related admissions increased from 15.1% of drug-related treatment admissions in 2008 to 23.6% in 2017. Increases occurred among nearly all demographic groups. Methamphetamine injection increased from 17.5% of admissions in 2008 to 28.4% in 2017. Among methamphetamine-related admissions, heroin use increased from 5.3% of admissions in 2008 to 23.6% in 2017. Characteristics associated with increased odds of reporting methamphetamine use at admission included female sex; admissions aged 35 to 44 years; admissions in the Midwest, South, and West; unemployment; not in labor force; living dependent; living homeless; and having a referral from criminal justice, a health care provider, or other community treatment source. Treatment admissions involving methamphetamine use increased significantly over the past decade and appear to be linked to the ongoing opioid crisis in the United States. Efforts to mobilize public health prevention, treatment, and response strategies to address rising methamphetamine use and overdose are needed.
评估美国甲基苯丙胺使用的趋势和相关因素。数据来自 2008 年至 2017 年治疗期数据集中年龄在 12 岁及以上的 15747334 例与药物相关的治疗入院。我们分析了趋势并使用多变量逻辑回归。与药物相关的治疗入院中，甲基苯丙胺相关入院从 2008 年的 15.1%增加到 2017 年的 23.6%。几乎所有的人口群体都出现了增长。2008 年，注射甲基苯丙胺的入院比例为 17.5%，2017 年上升至 28.4%。在甲基苯丙胺相关入院中，海洛因使用从 2008 年的 5.3%增加到 2017 年的 23.6%。与报告入院时使用甲基苯丙胺的几率增加相关的特征包括女性；35 至 44 岁的入院者；中西部、南部和西部的入院者；失业；未就业；依赖他人生活；无家可归；以及来自刑事司法、医疗保健提供者或其他社区治疗来源的转介。过去十年中，涉及甲基苯丙胺使用的治疗入院显著增加，似乎与美国持续的阿片类药物危机有关。需要动员公共卫生预防、治疗和应对策略，以解决甲基苯丙胺使用和过量用药的上升问题。
